Other
No treatment is included in this protocol.
No treatment is included in this protocol. is an intervention with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Trials by Status
recruiting267%
unknown133%
Recent Activity
2 active trials
Showing 3 of 3
recruiting
The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]
NCT02688894
recruiting
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
NCT06183762
unknown
A Real World Study Based on NGS (TRUMPRWS)
NCT03605602
Clinical Trials (3)
Showing 3 of 3 trials
NCT02688894
The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]
NCT06183762
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
NCT03605602
A Real World Study Based on NGS (TRUMPRWS)
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3